⌘K
Loading ticker…
As of 2026-08-24, Evolus, Inc. Common Stock (EOLS) has a 3-month relative strength percentile of 93 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 64. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.8%, relative volume 1.31×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
EOLS is held by 15 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $2M notional. Top 3 carry $5M.
Held by 25 ETFs · $25M across latest filings · largest weight 0.08% (IWC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VTWO | 0.01% | $2M | — |
| VHTVanguard Health Care ETF | 0.00% | $940K | — |
| GSSC | 0.05% | $478K | −0.02 pp |
| VTWG | 0.02% | $343K | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $302K |
| — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $32K | — |
| IBBQ | 0.03% | $22K | +0.01 pp |
| ITWO | 0.01% | $17K | — |
| BIB | 0.02% | $16K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EOLS Jan avg: 13.98% median: 23.53% win: 75% σ: 29.90% n: 4 2022-04-12 → 2026-07-31 | EOLS Feb avg: 0.07% median: -1.94% win: 50% σ: 13.35% n: 4 2022-04-12 → 2026-07-31 | EOLS Mar avg: -8.57% median: -6.16% win: 0% σ: 6.06% n: 4 2022-04-12 → 2026-07-31 | EOLS Apr avg: 2.59% median: -0.36% win: 40% σ: 17.53% n: 5 2022-04-12 → 2026-07-31 | EOLS May avg: 6.20% median: 9.86% win: 80% σ: 15.79% n: 5 2022-04-12 → 2026-07-31 | EOLS Jun avg: -7.96% median: -10.08% win: 40% σ: 10.77% n: 5 2022-04-12 → 2026-07-31 | EOLS Jul avg: 7.92% median: 6.29% win: 60% σ: 20.17% n: 5 2022-04-12 → 2026-07-31 | EOLS Aug avg: -2.47% median: -7.88% win: 25% σ: 22.01% n: 4 2022-04-12 → 2026-07-31 (current) | EOLS Sep avg: -10.35% median: -11.91% win: 25% σ: 9.62% n: 4 2022-04-12 → 2026-07-31 | EOLS Oct avg: -1.14% median: 2.98% win: 75% σ: 10.75% n: 4 2022-04-12 → 2026-07-31 | EOLS Nov avg: 0.98% median: -2.29% win: 50% σ: 20.14% n: 4 2022-04-12 → 2026-07-31 | EOLS Dec avg: -2.89% median: -1.70% win: 50% σ: 13.31% n: 4 2022-04-12 → 2026-07-31 |